darifenacin vs tolterodine
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of darifenacin and tolterodine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Enablex
Detrol
Darifenacin (Enablex) is a medicine that helps control an overactive bladder. It reduces the feeling of needing to go to the bathroom so often.
Tolterodine extended-release capsules help control an overactive bladder. It reduces the feeling of needing to go to the bathroom often.
This medicine treats overactive bladder. If you have overactive bladder, you may feel a sudden need to urinate. You may also urinate more often than normal, or leak urine.
This medicine treats overactive bladder. It helps reduce leaking urine, the strong need to urinate, and frequent urination. These symptoms are also known as urge urinary incontinence, urgency, and frequency.
Darifenacin blocks certain receptors in the bladder. These receptors cause the bladder muscles to contract. By blocking them, the medicine helps the bladder relax and hold more urine.
Tolterodine belongs to a class of drugs called antimuscarinics. It works by blocking certain nerve signals to the bladder. This helps to relax the bladder muscles and reduce the urge to urinate.
- • Dry mouth
- • Constipation
- • Headache
- • Upset stomach
- • Nausea
- • Dry mouth
- • Headache
- • Constipation
- • Abdominal pain
- Peripheral Swelling 91
- Herpes Zoster 83
- Pneumonia Viral 79
- Anaemia 59
- Arthralgia 59
- Fall 408
- Fatigue 406
- Dizziness 309
- Diarrhoea 308
- Nausea 308
If you have bladder problems that cause you to have trouble urinating, use darifenacin with caution because it could make it harder to urinate. Use caution if you have stomach or bowel blockage, as this medicine can make it worse. Darifenacin may cause sleepiness, so do not drive or operate heavy machinery until you know how it affects you. Angioedema (swelling of the face, lips, tongue, and/or throat) has been reported with darifenacin and can be life-threatening.
Anaphylaxis and angioedema (severe allergic reactions) have happened with this drug. These reactions can cause difficulty breathing and require emergency treatment. Use caution if you have bladder problems, gastrointestinal issues, or glaucoma. This medicine can cause sleepiness, so be careful driving or operating heavy machinery.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if darifenacin will harm your unborn baby. Talk to your doctor if you are breastfeeding or plan to breastfeed, as it is not known if darifenacin passes into breast milk.
It is not known if tolterodine is safe to use during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if tolterodine passes into breast milk. Talk to your doctor about the best way to feed your baby if you are taking this medicine.
Also Compare, Nearby Drugs
Compare darifenacin with
Compare tolterodine with
How to Read This darifenacin vs tolterodine Comparison
darifenacin is classified in the Anticholinergic (Overactive Bladder) drug class, while tolterodine sits within the Anticholinergic (Overactive Bladder) class. Because both drugs share the same classification, they are often considered interchangeable in theory, but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, darifenacin has 371 submissions while tolterodine has 1,739. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for darifenacin or tolterodine.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.